PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement ...

Investments of 3 billion Swiss francs in modern research infrastructure, attractive workplaces and sustainable site development Today Roche presented development plans for its Basel site. Over the ...

ZURICH (Reuters) - Drugmaker Roche (ROG.VX) is spending billions of dollars constructing the two tallest buildings in Switzerland for its global HQ, a vote of confidence in its Swiss base despite ...

Following in the footsteps of other Big Pharma heavyweights, Roche ($RHHBY) is giving its corporate headquarters a multibillion-dollar facelift. The drugmaker will ...

Basel Area Business & Innovation, the strategic growth partner helping ventures in science and tech to land, launch and level ...

Roche said today it will spend CHF 3 billion ($3.15 billion) over the next 10 years on enhancements to its headquarters site in Basel, Switzerland. The pharma giant plans to construct a new R&D center ...

Roche plans to spend around $3bn updating and expanding its Basal site, home to the Swiss company’s headquarters, over the next 10 years. The company is set to build a new R&D centre for 1,900 ...

Switzerland’s most innovative research and development center underscores Roche’s long-term investment in scientific advancement to meet patient needs The new center will simplify and increase ...

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to ...